Light-activated compound kills cancer cells leaving normal cells unharmed when piggybacked with cancer-seeking antibodies

Madely Health Headlines Commentary for November 16, 2011

Source:

Light-activated cancer drugs tested

Reference:

National Cancer Institute

Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules

Bitnami